Technical Service Need help? Our team of experienced experts is here for you with full support.
AKA-48
Cefotaxime
Cat. No.
AKA-48
CAS No.
63527-52-6
MF
C16H17N5O7S2
MW
455.5
Cefotaxime is a β-lactamase-stable third-generation cephalosporin compound with broad-spectrum activity against Gram-positive and Gram-negative bacteria.
Advanced Equipments & Extensive Production Expertise
Commercial Manufacturing
Stable Quality
Customization Supporting
Technical Service 
86-28-85159085 
info@aktin.com
Technical Data
Description
Storage and Shipping
References
Product Name
Cefotaxime
CAS No.
63527-52-6
MF
C16H17N5O7S2
MW
455.5
Specification
99%
Research Area
Intermediate
Description
Cefotaxime is a β-lactamase-stable third-generation cephalosporin compound with broad-spectrum activity against Gram-positive and Gram-negative bacteria. Packing: 1kg/bag; 25kg/drum or as request Availability: In Stock
Documents
Certificate of Analysis (COA), API specification, Safety Data Sheet (SDS/MSDS), evidence of GMP compliance, Stability data / Stability summary, etc.
Storage and Shipping
Store in a cool & dry place, keep away from strong light and heat.
References
[1]. Jang HC, et al. In vivo efficacy of the combination of ciprofloxacin and cefotaxime against Vibrio vulnificus sepsis. PloS One. 2014 Jun 30;9(6):e101118. PMID: 24978586
[2]. Woodfield JC, et al. A comparison of the prophylactic efficacy of ceftriaxone and cefotaxime in abdominal surgery. American Journal of Surgery. 2003 Jan;185(1):45-9. PMID: 12531444
[3]. Scholz H, et al. Prospective comparison of ceftriaxone and cefotaxime for the short-term treatment of bacterial meningitis in children. Chemotherapy. 1998 Mar-Apr;44(2):142-7. PMID: 9551246
[4]. Gums JG, et al. Differences between ceftriaxone and cefotaxime: microbiological inconsistencies. The Annals of Pharmacotherapy. 2008 Jan;42(1):71-9. PMID: 18094350
[5]. Francke EL, et al. Use of cefotaxime, a beta-lactamase stable cephalosporin, in the therapy of serious infections, including those due to multiresistant organisms. The American Journal of Medicine. 1981 Sep;71(3):435-42. PMID: 6269426
[2]. Woodfield JC, et al. A comparison of the prophylactic efficacy of ceftriaxone and cefotaxime in abdominal surgery. American Journal of Surgery. 2003 Jan;185(1):45-9. PMID: 12531444
[3]. Scholz H, et al. Prospective comparison of ceftriaxone and cefotaxime for the short-term treatment of bacterial meningitis in children. Chemotherapy. 1998 Mar-Apr;44(2):142-7. PMID: 9551246
[4]. Gums JG, et al. Differences between ceftriaxone and cefotaxime: microbiological inconsistencies. The Annals of Pharmacotherapy. 2008 Jan;42(1):71-9. PMID: 18094350
[5]. Francke EL, et al. Use of cefotaxime, a beta-lactamase stable cephalosporin, in the therapy of serious infections, including those due to multiresistant organisms. The American Journal of Medicine. 1981 Sep;71(3):435-42. PMID: 6269426
Disclaimer
This product is intended solely for scientific research or regulatory filing purposes. We do not provide products or services to individuals, please strictly comply with all applicable laws, regulations, and the committed use. Use for any other purpose is strictly prohibited.
Related Products
AKA-384
Tedizolid phosphate
CAS No.: 856867-55-5
MF:C17H16FN6O6P
AKA-383
Brivaracetam
CAS No.:357336-20-0
MF:C11H20N2O2
AKA-382
Cobimetinib Fumarate
CAS No.:1369665-02-0
MF:C46H46F6I2N6O8
AKA-379
Bempedoic acid
CAS No.:738606-46-7
MF:C19H36O5
AKA-378
Borofalan(10B)
CAS No.:80994-59-8
MF:C9H12BNO4
AKA-377
AkProva™ Metildigoxin
CAS No.:30685-43-9(acetone-free)
MF:C42H66O14.1/2C3H6O
AKA-376
AkProva™ beta-Acetyldigoxin
CAS No.:5355-48-6
MF:C43H66O15
AKA-375
Ak-NucleoVia™ Agrostemmoside E
CAS No.:2656438-29-6
MF:C84H128O45
AKA-374
Novobiocin sodium
CAS No.:1476-53-5
MF:C31H35N2NAO11
AKA-360
Travoprost
CAS No.:157283-68-6
MF:C26H35F3O6
* Some statements have not been evaluated by national authorities. * Some products are not intended to diagnose, treat, cure, or prevent any disease. * For literature supporting, please contact us directly.
